Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person PubChem Substance

Class:IdReferenceDatabase:183154
_displayNamePubChem Substance
_timestamp2026-03-09 03:04:14
accessUrlhttps://pubchem.ncbi.nlm.nih.gov/substance/###ID###
created[InstanceEdit:183153] de Bono, B, 2006-07-24 11:17:04
identifiersPrefixpubchem.substance
modified[InstanceEdit:183159] de Bono, B, 2006-07-24 14:26:09
[InstanceEdit:9982918] Weiser, Joel, 2026-02-20
[InstanceEdit:9984513] Matthews, Lisa, 2026-03-09
namePubChem Substance
resourceIdentifierMIR:00100058
urlhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pcsubstance
(referenceDatabase)[ReferenceTherapeutic:9709456] Epoetin theta [PubChem Substance:135315770]
[ReferenceTherapeutic:9709458] Methoxy polyethylene glycol-epoetin beta [PubChem Substance:347910408]
[ReferenceTherapeutic:9709459] Epoetin zeta [PubChem Substance:160703832]
[ReferenceTherapeutic:9709464] Epoetin beta [PubChem Substance:46508122]
[ReferenceTherapeutic:9709471] Darbepoetin alfa [PubChem Substance:46504480]
[ReferenceTherapeutic:9734434] peginterferon alfa-2a [PubChem Substance:47205819]
[ReferenceTherapeutic:9845100] Palivizumab [PubChem Substance:472423423]
[ReferenceTherapeutic:9845134] Nirsevimab [PubChem Substance:472418861]
[ReferenceTherapeutic:9845135] Gontivimab [PubChem Substance:472419397]
[ReferenceTherapeutic:9845185] Asvasiran [PubChem Substance:472406334]
List all 867 refering instances
[Change default viewing format]
No pathways have been reviewed or authored by PubChem Substance (183154)